Previous 10 | Next 10 |
WILMETTE, Ill., March 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced positive preclinical imaging data of a therapeutic radioisotope bound to its pro...
WILMETTE, Ill., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that the internationally recognized radiopharmaceutical physician, Professor Rodn...
2024-02-24 06:13:00 ET 3 Reasons Why Penny Stocks Shoot Up in Value Penny stocks represent a unique segment of the market, offering investors the potential for significant returns on their investments. These stocks, typically priced below $5 per share, can climb in price for a variety o...
2024-02-23 12:38:45 ET More on Mid-day movers & stocks. Financial information for Arisz Acquisition Corp. Financial information for Pop Culture Financial information for Primech Holdings Ltd. Compare metrics for ARIZ to CPOP, PMEC Read the full ...
2024-02-23 10:22:53 ET DENVER, Colo., Feb 23, 2024 (www.247marketnews.com)- Monopar Therapeutics Inc. (NASDAQ: MNPR ) has already exceeded its outstanding share count and is about to turn its float over for the third time this morning. Monopar is trading at $1.3366, up $0.2166 (+19....
2024-02-23 10:00:17 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming UBS concedes it wasn't bullis...
2024-02-23 06:53:00 ET How to Identify Trends With Penny Stocks to Profit in 2024 Identifying trends in penny stock trading is a pivotal strategy for investors aiming to profit in 2024. The journey to success involves deep research, leveraging technical analysis, and keeping a pulse on ...
2024-02-22 12:26:58 ET More on Mid-day movers & stocks. CSP Inc. (CSPI) Q1 2024 Earnings Call Transcript CSP Inc.'s Game Changing Product Launch Offers An Investment Opportunity CSP Inc. (CSPI) Q4 2023 Earnings Call Transcript CSP announces 2-for-1 stock ...
A look at the top 10 most actives in the United States Nikola Corporation (NKLA) fell 4.6% to $0.7055 on volume of 174,330,167 shares PROSHARES TRUST (SQQQ) rose 2.3% to $11.92 on volume of 147,409,535 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.0% to $4.61 on volume ...
2024-02-21 06:07:00 ET 3 Top Rules for Buying and Selling Penny Stocks in 2024 Trading penny stocks presents an exciting opportunity for investors looking to diversify their portfolios and tap into the potential for significant returns. These stocks, typically priced below $5, offer a u...
News, Short Squeeze, Breakout and More Instantly...
Monopar Therapeutics Inc. Company Name:
MNPR Stock Symbol:
NASDAQ Market:
Monopar Therapeutics Inc. Website:
WILMETTE, Ill., July 09, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced the enrollment of the first patient in its first-in-human Phase 1 dosimetry and imaging...
WILMETTE, Ill., June 25, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced that its abstract titled “Evaluation of Anti-uPAR Antibody as a Radiopharmaceuti...
Highlights: Builds on Companies’ respective core strengths Aligns intellectual property rights Establishes a long-term supply agreement under which NorthStar provides actinium-225 for Monopar’s development and potential future commercial programs WILMETTE, ...